skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > organooxygen compound > polyketide > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > macrolide antibiotic > mycinamicin > mycinamicin vi

Preferred term

mycinamicin vi  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C35H57NO11

inchi

  • InChI=1S/C35H57NO11/c1-9-27-24(18-43-34-32(42)31(41)29(39)23(6)45-34)12-10-11-13-26(37)20(3)16-21(4)33(19(2)14-15-28(38)46-27)47-35-30(40)25(36(7)8)17-22(5)44-35/h10-15,19-25,27,29-35,39-42H,9,16-18H2,1-8H3/b12-10+,13-11+,15-14+/t19-,20+,21-,22+,23+,24+,25-,27+,29+,30+,31+,32+,33+,34+,35-/m0/s1

inchikey

  • ORPUAOXOPLNKNG-GEUQSOIWSA-N

mass

  • 667.82720

monoisotopicmass

  • 667.39316

smiles

  • CC[C@H]1OC(=O)/C=C/[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@H](C)C[C@@H](C)C(=O)/C=C/C=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](O)[C@H]1O

subset

  • 3_STAR

synonym EXACT

  • [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-beta-D-allopyranoside

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:63285

Download this concept:

RDF/XML TURTLE JSON-LD